Services on Demand
Journal
Article
Spanish (pdf)
Article in xml format
Article references
Automatic translation
Send this article by e-mailIndicators
Cited by SciELO 
Access statistics
Related links
Similars in
SciELO
Share
Permalink
Gaceta mexicana de oncología
On-line version ISSN 2565-005XPrint version ISSN 1665-9201
Abstract
CERVANTES-ZAMORA, Antonio et al. Hyperthermic intraperitoneal chemotherapy (HIPEC) + Cytoreductive surgery in ovarian cancer. Gac. mex. oncol. [online]. 2022, vol.21, suppl.1, pp.102-104. Epub Sep 11, 2023. ISSN 2565-005X. https://doi.org/10.24875/j.gamo.22000005.
Background:
Ovarian cancer is the fifth leading cause of cancer death and the prevalence with peritoneal metastasis is high, with a low possibility of cure.
Case presentation:
33-year-old patient with ovarian cancer and peritoneal metastasis treated with Radical Cytoreductive Surgery + Hyperthermic Intraperitoneal Chemotherapy and disease-free at 2 years of follow-up.
Discussion:
There is evidence of increased survival of intraperitoneal chemotherapy, with a 21% reduction in the risk of death.
Conclusion:
This treatment can be applied as a promising and possibly curative option for this disease.
Keywords : Carcinomatosis; Cancer; Ovary; HIPEC.
